Back to today’s briefing

Story perspectives

New Drug Prices Surge to $370K; CivicaScript Cuts Cancer Costs

5/24/2025

36 2

Summary

Story summary

In 2024, the median price for new drugs skyrocketed to over $370,000, more than double the figure from 2021. A staggering 72% of these drugs target rare diseases. Meanwhile, CivicaScript has made waves by slashing costs for a generic cancer drug, delivering a remarkable 64% savings for patients and 92% for payers since its 2022 launch.

1 of 1

Story summary

In 2024, the median price for new drugs skyrocketed to over $370,000, more than double the figure from 2021. A staggering 72% of these drugs target rare diseases. Meanwhile, CivicaScript has made waves by slashing costs for a generic cancer drug, delivering a remarkable 64% savings for patients and 92% for payers since its 2022 launch.